CompletedNCT06766214
Attexis and tDCS studied together for ADHD
About this title
Read the official source — NCT06766214Device studyAges 18–65Germany
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- RegensburgSee all locations and recruitment
Study information
Study start dateStarted: September 1, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- University of Regensburg
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- Germany
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06766214
- Official title
Show the full official title
Augmentation Von Online-Psychotherapie Mit tDCS Bei Der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Regensburg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Regensburg, a university.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to explore more studies?
Explore studiesRelated studies
Brain feedback training and impulse control
A 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-onset ADHD